Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1754 of 5804
-
Heart drug pelacarsen tested for Long-Term safety in 5,700 patients
Disease control Recruiting nowThis open-label extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed the double-blind parent study (CTQJ230A12301).
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Swallow a robot camera instead of a tube? new trial tests less scary anaemia exam
Diagnosis Recruiting nowIn this study the investigators will recruit patients who have already had an upper gastrointestinal (GI) tract endoscopy (OGD) and lower GI tract investigations which did not identify the source of iron deficiency anaemia, and who need the small bowel to be investigated. This wi…
Phase: NA • Sponsor: University of Edinburgh • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
New cancer drug TAK-505 enters first human trials
Disease control Recruiting nowSolid tumors occur when cells in an organ or tissue (for example in the lung or liver) start growing out of control (cancer) and form a lump or mass of cells. These solid cancers may grow very far in the general area where they started (called locally advanced) or may spread to o…
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New MRI technique may sharpen diagnosis of multiple sclerosis in older adults
Knowledge-focused Recruiting nowThis study investigates whether an advanced MRI technique called Quantitative Susceptibility Mapping (QSM) can improve the differentiation of white matter lesions in people aged 50-70 years with multiple sclerosis (MS). In older individuals with MS, white matter changes seen on M…
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Could cutting immune drugs save kidney transplants during severe infections?
Disease control Recruiting nowKidney transplantation is the treatment of choice for end-stage chronic kidney disease. Kidney transplantation is at the first rank of solid organ transplantation in France, with 3,376 grafts performed in 2022. Immunosuppressive therapy, required to prevent graft rejection, expos…
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Robots take on knee surgery: a new trial for PCL fractures
Disease control Not yet recruitingThe primary objective of this clinical trial is to evaluate the efficacy of robotic-assisted surgery in the management of posterior cruciate ligament (PCL) avulsion fractures involving the tibial insertion site of the cruciate ligament. Specifically, the study seeks to determine:…
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Blood pressure breakthrough? device shows promise for High-Altitude hypertension
Disease control Not yet recruitingThis study is a multicenter, prospective, randomized, open-label, parallel-controlled clinical trial. The study participants are adult patients with hypertension who have been long-term residents (for \>6 months) in high-altitude regions (≥2500 m). They are randomly assigned to o…
Phase: PHASE3 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Which vaccine schedule works best? new study aims to protect babies from pneumococcal disease
Prevention Not yet recruitingTo compare the immunogenicity of the domestically produced PCV13 vaccine in healthy 2-month-old infants following administration via the 2+1 and 3+1 schedules, with the primary endpoint being the seroprevalence of specific IgG antibodies after completion of the vaccination series…
Phase: NA • Sponsor: Beijing Center for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New oral painkiller aims to ease recovery after orthopedic surgery
Symptom relief Recruiting nowThis clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery.
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Sound wave device aims to crack hardened heart arteries
Disease control Recruiting nowA prospective, open-label, multi-site, FIH with up to fifteen (n=15) patients to assess the safety and preliminary effectiveness of the AVS Pulse Intravascular Lithotripsy™ System (Pulse IVL™ System) when used for the treatment of coronary artery disease.
Phase: NA • Sponsor: Amplitude Vascular Systems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New gel treatment for Parkinson's aims to reduce 'Off' time
Disease control Recruiting nowThe primary objective of the study is to assess the effectiveness of LECIGON® treatment on the reduction in OFF time (h/day) from baseline at 12 months as measured by Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part IV (MDS-UPDRS IV).
Sponsor: Britannia Pharmaceuticals Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New injection could shrink nasal polyps without surgery
Disease control Not yet recruitingThis is a randomized, multicenter, double-blind, Phase 3 study with 2 parallel groups. The purpose of this study is to evaluate the efficacy, safety, and tolerability of 2 different dosing regimens of itepekimab monotherapy in Japanese participants aged 18 years or older with chr…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Robot vs surgeon: which knee replacement works better?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the VELYS Robotic-Assisted Solution (VRAS) device helps to improve outcomes from total knee replacement, when compared to regular non-robotic-assisted total knee replacement in the treatment of osteoarthritis. It will also aim to rev…
Phase: NA • Sponsor: Golden Jubilee National Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Experimental 'Off-the-Shelf' CAR-T therapy takes on tough lymphoma
Disease control Not yet recruitingThis single-arm, open-label pilot study will assess the safety and efficacy of RN1701, a bispecific CD19/CD20-targeted allogeneic CAR-T-cell product, in patients with relapsed or refractory B-cell lymphoma. Up to 19 participants will be enrolled in a conventional 3 + 3 dose-escal…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo heart procedure aims to cut stroke risk and improve heart function in AF patients
Disease control ENROLLING_BY_INVITATIONThis study is a prospective, multicenter, single-blinded, randomized controlled trial to investigate whether concomitant left atrial appendage closure (LAAC) and pulsed field ablation (PFA) is more effective than LAAC alone in improving the outcomes in persistent atrial fibrillat…
Phase: NA • Sponsor: Sir Run Run Shaw Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Online brain health course could slash dementia risk
Prevention Recruiting nowThis study will recruit participants at risk for dementia to participate in an online educational program called Brain Health PRO (BHPro). The BHPro intervention is designed to address modifiable risk factors for dementia through a 6-month, fully online, educational program conve…
Phase: NA • Sponsor: University of British Columbia • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
AI app aims to speed up labor decisions for doctors and nurses
Knowledge-focused Recruiting nowPregnancy and childbirth are uniquely important events in women's lives because they are accompanied by major physical, emotional, and psychological changes. Maternal satisfaction, emotional well-being, and perceptions of childbirth are strongly influenced by the quality of labor…
Phase: NA • Sponsor: Delta University for Science and Technology • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
New COPD drug tozorakimab moves to Long-Term safety check
Disease control Recruiting nowROMEO is a Phase III, multicentre, open-label, chronic-dosing extension study evaluating the long-term safety of two dose regimens of tozorakimab in participants with COPD and a history of exacerbations. Eligible participants must have completed one of the predecessor studies.
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a simple shot replace IV drips for Alpha-1 patients?
Disease control Recruiting nowThis study is designed to compare two different weekly doses of a medicine called Alpha1-Proteinase Inhibitor given by injection under the skin with the standard doses of the same medicine given through a vein. Adults with Alpha-1 Antitrypsin Deficiency will take part. Participa…
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Elastic band workouts show promise in fighting muscle loss in elderly
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the effectiveness of progressive resistance training using elastic bands in treating and delaying the progression of sarcopenia among older adults in long-term care facilities. Sarcopenia, characterized by a progressive decline in mu…
Phase: NA • Sponsor: Cishan Hospital, Ministry of Health and Welfare • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC